The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Onaitis Matthew since year 2005.
The trader's CIK number is 1362822.
At the time of this reporting, Onaitis Matthew is the VP, General Counsel of Somaxon Pharmaceuticals, Inc. .
(stock ticker symbol SOMX).
See this page for all insider trading activities at Somaxon Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-01-03||SOMX||Somaxon Pharmaceuticals, Inc.||Sale||9,000||.48||4,293|
|2010-12-01||SOMX||Somaxon Pharmaceuticals, Inc.||Sale||8,468||2.68||22,728|
|2010-03-18||SOMX||Somaxon Pharmaceuticals, Inc.||Sale||32,081||7.53||241,602|
|2010-03-18||SOMX||Somaxon Pharmaceuticals, Inc.||Option Ex||29,454||1.23||36,228|
|2010-03-01||SOMX||Somaxon Pharmaceuticals, Inc.||Sale||30,000||4.02||120,480|
|2010-03-01||SOMX||Somaxon Pharmaceuticals, Inc.||Option Ex||30,000||1.23||36,900|
|2010-02-05||SOMX||Somaxon Pharmaceuticals, Inc.||Sale||60,000||3.02||181,500|
|2010-02-05||SOMX||Somaxon Pharmaceuticals, Inc.||Option Ex||60,000||1.23||73,800|
|2009-12-31||SOMX||Somaxon Pharmaceuticals, Inc.||Sale||5,000||1.07||5,350|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Onaitis Matthew (VP, General Counsel of Somaxon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.